Effect of Concomitant Radiochemotherapy on Invasion Potential of Glioblastoma.

作者: Gábor Hutóczki , László Bognár , Judit Tóth , Beáta Scholtz , Gábor Zahuczky

DOI: 10.1007/S12253-015-9989-5

关键词:

摘要: Glioblastoma (GBM) is the most common primary brain tumor in adults with inevitable recurrence after oncotherapy. The insufficient effect of "gold standard" temozolomide-based concomitant radiochemotherapy may be due to inability prevent cell invasion. Peritumoral infiltration depends mainly on interaction between extracellular matrix (ECM) components and membrane receptors. Changes invasive behaviour oncotherapy can evaluated at molecular level by determining RNA expression protein levels invasion-related ECM components. nineteen molecules was determined both thirty-one GBM samples. Fifteen samples originated from first surgical procedure patients before oncotherapy, sixteen were collected second surgery local chemoirradiation. expressions measured qRT-PCR, quantitative analysis Western blots. Only MMP-9 transcript reduced (p < 0.05) whereas level, eight showed changes concordant significant decrease brevican only. results suggest that does not have sufficient impact glioblastoma, significantly affect its behavior. To avoid spread tumors into parenchyma, supplementation antiproliferative treatment anti-invasive agents worth consideration for glioblastoma.

参考文章(38)
Miklós Petrás, Gábor Hutóczki, Imre Varga, György Vereb, János Szöllosi, László Bognár, Péter Ruszthi, Annamária Kenyeres, Judit Tóth, Zoltán Hanzély, Beáta Scholtz, Almos Klekner, None, [Expression pattern of invasion-related molecules in brain tumors of different origin]. Magyar onkologia. ,vol. 53, pp. 253- ,(2009) , 10.1556/MONKOL.53.2009.3.3
Carsten Nieder, Nicolaus Andratschke, Nicole Wiedenmann, Raymonde Busch, Anca L. Grosu, Michael Molls, Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? Strahlentherapie Und Onkologie. ,vol. 180, pp. 401- 407 ,(2004) , 10.1007/S00066-004-1220-7
I. Varga, G. Hutóczki, M. Petrás, B. Scholtz, E. Mikó, A. Kenyeres, J. Tóth, G. Zahuczky, L. Bognár, Z. Hanzély, A. Klekner, Expression of invasion-related extracellular matrix molecules in human glioblastoma versus intracerebral lung adenocarcinoma metastasis. Central European Neurosurgery. ,vol. 71, pp. 173- 180 ,(2010) , 10.1055/S-0030-1249698
Daniela Trog, Kristina Yeghiazaryan, Michael Fountoulakis, Arno Friedlein, Heike Moenkemann, Nicolai Haertel, Heinrich Schueller, Winrich Breipohl, Hans Schild, David Leppert, Olga Golubnitschaja, Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells. European Journal of Pharmacology. ,vol. 542, pp. 8- 15 ,(2006) , 10.1016/J.EJPHAR.2006.05.026
Cristina Iuga, Andrada Seicean, Cornel Iancu, Rareş Buiga, Praveen K. Sappa, Uwe Völker, Elke Hammer, Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma. Proteomics. ,vol. 14, pp. 945- 955 ,(2014) , 10.1002/PMIC.201300402
A. P. Andersen, Postoperative irradiation of glioblastomas. Results in a randomized series. Acta radiologica: oncology, radiation, physics, biology. ,vol. 17, pp. 475- 484 ,(1978) , 10.3109/02841867809128178
Richard T. Blankley, Christal Fisher, Melissa Westwood, Robyn North, Philip N. Baker, Michael J. Walker, Andrew Williamson, Anthony D. Whetton, Wanchang Lin, Lesley McCowan, Claire T. Roberts, Garth J. S. Cooper, Richard D. Unwin, Jenny E. Myers, A Label-free Selected Reaction Monitoring Workflow Identifies a Subset of Pregnancy Specific Glycoproteins as Potential Predictive Markers of Early-onset Pre-eclampsia Molecular & Cellular Proteomics. ,vol. 12, pp. 3148- 3159 ,(2013) , 10.1074/MCP.M112.026872
James G. Gurney, Nina Kadan-Lottick, Brain and other central nervous system tumors: rates, trends, and epidemiology Current Opinion in Oncology. ,vol. 13, pp. 160- 166 ,(2001) , 10.1097/00001622-200105000-00005
Haider A. Shirazi, Sean Grimm, Jeffrey Raizer, Minesh P. Mehta, Combined Modality Approaches in the Management of Adult Glioblastoma Frontiers in Oncology. ,vol. 1, pp. 36- 36 ,(2011) , 10.3389/FONC.2011.00036